Reassessing AbCellera Biologics (ABCL) After A Sharp 16.8% Weekly Share Price Drop
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.
-
If you are wondering whether AbCellera Biologics shares are priced attractively today, this article walks through what the current market price might be suggesting about value.
-
The stock last closed at US$3.86, after a 16.8% decline over the past 7 days, while returns over 30 days, year to date, and the last year are 11.9%, 12.5%, and 19.5% respectively. This compares with a 64.9% decline over 3 years and a 91.7% decline over 5 years.
-
Recent price moves sit against an ongoing investor focus on AbCellera Biologics as a drug discovery and development business. Sentiment can shift quickly as…
